Annual Total Expenses
$41.83 M
-$8.80 M-17.38%
01 June 2022
Summary:
Pluristem Therapeutics annual total expenses is currently $41.83 million, with the most recent change of -$8.80 million (-17.38%) on 01 June 2022. During the last 3 years, it has fallen by -$8.80 million (-17.38%).PSTI Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$7.01 M
-$1.87 M-21.08%
01 September 2022
Summary:
Pluristem Therapeutics quarterly total expenses is currently $7.01 million, with the most recent change of -$1.87 million (-21.08%) on 01 September 2022.PSTI Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -17.4% | -38.7% |
| 5 y5 years | +17.5% | -2.6% |
PSTI Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -17.4% | -51.9% |
Pluristem Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $7.01 M(-21.1%) |
| June 2022 | $41.83 M(-17.4%) | $8.88 M(-17.1%) |
| Mar 2022 | - | $10.71 M(-0.8%) |
| Dec 2021 | - | $10.79 M(-5.6%) |
| Sept 2021 | - | $11.44 M(-21.6%) |
| June 2021 | $50.62 M(+71.6%) | $14.59 M(+2.5%) |
| Mar 2021 | - | $14.22 M(+8.8%) |
| Dec 2020 | - | $13.07 M(+49.6%) |
| Sept 2020 | - | $8.74 M(+2.6%) |
| June 2020 | $29.50 M(-17.1%) | $8.51 M(+15.1%) |
| Mar 2020 | - | $7.40 M(+15.8%) |
| Dec 2019 | - | $6.39 M(-11.2%) |
| Sept 2019 | - | $7.20 M(-9.3%) |
| June 2019 | $35.59 M(+5.3%) | $7.93 M(-23.0%) |
| Mar 2019 | - | $10.30 M(+22.9%) |
| Dec 2018 | - | $8.38 M(-6.6%) |
| Sept 2018 | - | $8.97 M(+2.3%) |
| June 2018 | $33.78 M(+20.6%) | $8.78 M(-3.0%) |
| Mar 2018 | - | $9.05 M(+6.2%) |
| Dec 2017 | - | $8.52 M(+14.5%) |
| Sept 2017 | - | $7.44 M(+13.0%) |
| June 2017 | $28.02 M(+7.1%) | $6.59 M(-19.9%) |
| Mar 2017 | - | $8.22 M(+23.7%) |
| Dec 2016 | - | $6.65 M(+1.3%) |
| Sept 2016 | - | $6.56 M(+6.3%) |
| June 2016 | $26.17 M(+2.0%) | $6.17 M(-16.5%) |
| Mar 2016 | - | $7.39 M(+5.9%) |
| Dec 2015 | - | $6.98 M(+24.2%) |
| Sept 2015 | - | $5.62 M(-4.9%) |
| June 2015 | $25.65 M(-9.2%) | $5.91 M(-22.5%) |
| Mar 2015 | - | $7.62 M(+19.2%) |
| Dec 2014 | - | $6.40 M(+11.9%) |
| Sept 2014 | - | $5.72 M(-16.0%) |
| June 2014 | $28.23 M(+23.3%) | $6.81 M(-27.4%) |
| Mar 2014 | - | $9.38 M(+32.4%) |
| Dec 2013 | - | $7.08 M(+43.0%) |
| Sept 2013 | - | $4.96 M(-32.2%) |
| June 2013 | $22.90 M(+45.4%) | $7.31 M(+19.3%) |
| Mar 2013 | - | $6.13 M(+20.6%) |
| Dec 2012 | - | $5.08 M(+15.8%) |
| Sept 2012 | - | $4.38 M(+7.7%) |
| June 2012 | $15.75 M | $4.07 M(-15.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $4.84 M(+106.0%) |
| Dec 2011 | - | $2.35 M(-47.6%) |
| Sept 2011 | - | $4.49 M(+16.9%) |
| June 2011 | $11.11 M(+49.4%) | $3.84 M(+42.2%) |
| Mar 2011 | - | $2.70 M(-4.4%) |
| Dec 2010 | - | $2.82 M(+61.0%) |
| Sept 2010 | - | $1.75 M(+1.9%) |
| June 2010 | $7.44 M(+13.4%) | $1.72 M(-23.7%) |
| Mar 2010 | - | $2.26 M(+23.9%) |
| Dec 2009 | - | $1.82 M(-27.2%) |
| Sept 2009 | - | $2.50 M(+52.8%) |
| June 2009 | $6.56 M(-37.1%) | $1.64 M(-14.2%) |
| Mar 2009 | - | $1.91 M(+134.9%) |
| Dec 2008 | - | $813.00 K(-63.0%) |
| Sept 2008 | - | $2.20 M(-19.4%) |
| June 2008 | $10.43 M(+66.2%) | $2.72 M(-0.9%) |
| Mar 2008 | - | $2.75 M(+7.3%) |
| Dec 2007 | - | $2.56 M(+7.0%) |
| Sept 2007 | - | $2.39 M(-17.4%) |
| June 2007 | $6.28 M(+169.1%) | $2.90 M(+47.5%) |
| Mar 2007 | - | $1.97 M(+219.5%) |
| Dec 2006 | - | $615.00 K(-22.7%) |
| Sept 2006 | - | $796.00 K(-0.3%) |
| June 2006 | $2.33 M(-12.4%) | $798.30 K(+32.8%) |
| Mar 2006 | - | $601.10 K(+27.7%) |
| Dec 2005 | - | $470.60 K(+1.8%) |
| Sept 2005 | - | $462.20 K(-7.2%) |
| June 2005 | $2.66 M(-67.9%) | $497.80 K(-60.9%) |
| Mar 2005 | - | $1.27 M(+206.4%) |
| Dec 2004 | - | $415.50 K(-12.5%) |
| Sept 2004 | - | $474.70 K(-92.7%) |
| June 2004 | $8.28 M(+3834.9%) | $6.47 M(+469.2%) |
| Mar 2004 | - | $1.14 M(+218.4%) |
| Dec 2003 | - | $357.10 K(+12.7%) |
| Sept 2003 | - | $316.90 K(+91.1%) |
| June 2003 | $210.50 K(+182.6%) | $165.80 K(+2302.9%) |
| Mar 2003 | - | $6900.00(-65.5%) |
| Dec 2002 | - | $20.00 K(+11.7%) |
| Sept 2002 | - | $17.90 K(-20.4%) |
| June 2002 | $74.50 K | $22.50 K(+17.2%) |
| Mar 2002 | - | $19.20 K(+42.2%) |
| Dec 2001 | - | $13.50 K |
FAQ
- What is Pluristem Therapeutics annual total expenses?
- What is the all time high annual total expenses for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Pluristem Therapeutics?
What is Pluristem Therapeutics annual total expenses?
The current annual total expenses of PSTI is $41.83 M
What is the all time high annual total expenses for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual total expenses is $50.62 M
What is Pluristem Therapeutics quarterly total expenses?
The current quarterly total expenses of PSTI is $7.01 M
What is the all time high quarterly total expenses for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly total expenses is $14.59 M